CTLA4-Ig PLUS BONE MARROW INDUCES LONG-TERM ALLOGRAFT SURVIVAL AND DONOR-SPECIFIC UNRESPONSIVENESS IN THE MURINE MODEL
- 15 April 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (7) , 997-1004
- https://doi.org/10.1097/00007890-199604150-00002
Abstract
Allograft rejection is dependent on T cell activation, which requires both the engagement of the T cell receptor by antigen in the context of the MHC molecule and costimulatory signals delivered by cell surface molecules such as the B7-CD28/CTLA4 pathway. CTLA4-Ig is a fusion protein that blocks this pathway and has previously been shown to prolong both allograft and xenograft survival. The current study demonstrates markedly prolonged murine cardiac allograft survival and specific prolongation of secondary skin grafts using a combination of CTLA4-Ig plus donor bone marrow. A role for hematopoietic chimerism in the establishment of CTLA4-Ig-induced transplantation tolerance was investigated using reverse transcriptase polymerase chain reaction analysis of recipient tissues. Expression of donor-specific MHC class II transcripts in both peripheral and lymphoid tissues was demonstrated at greater than 200 days after transplant. To investigate the functional significance of this observation, heart donors and donor bone marrow were irradiated before transplantation in CTLA4-Ig-treated recipients. A reduction in allograft survival was associated with irradiation of both the donor heart and the bone marrow. These results suggest that there may be a donor-derived radiosensitive element that enhances allograft survival in this model. Reverse transcriptase polymerase chain reaction analysis of allografts of tolerant and control animals at days 5, 8, and 12 after transplantation failed to demonstrate a dramatic difference in the expression of interleukin (IL)-2, IL-4, IL-10, and interferon-γ message. Cytotoxicity effector transcripts were largely intact in CTLA4-Ig + bone marrow-treated recipients as they showed no decrease in intragraft granzyme, perforin, Fas, or Fas ligand transcripts during the first 8 days after transplant. These results imply that complex mechanisms may be important for the induction and maintenance of transplantation tolerance in the CTLA4-Ig plus bone marrow murine cardiac allograft model.Keywords
This publication has 36 references indexed in Scilit:
- DONOR-RECIPIENT MICROCHIMERISM IS NOT REQUIRED FOR TOLERANCE INDUCTION FOLLOWING RECIPIENT PRETREATMENT WITH DONOR-SPECIFIC TRANSFUSION AND ANTI-CD4 ANTIBODYTransplantation, 1995
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1Transplantation, 1994
- Peripheral microchimerism in long-term cadaveric-kidney allograft recipientsThe Lancet, 1994
- FURTHER STUDIES OF VETO ACTIVITY IN RHESUS MONKEY BONE MARROW IN RELATION TO ALLOGRAFT TOLERANCE AND CHIMERISMTransplantation, 1994
- SIMILAR LEVELS OF GRANZYME A AND PERFORIN mRNA EXPRESSION IN REJECTED AND TOLERATED HEART ALLOGRAFTS IN DONOR-SPECIFIC TOLERANCE IN RATSTransplantation, 1993
- Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.The Journal of Experimental Medicine, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cellsImmunology Today, 1991
- Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell ClonesScience, 1991